Susquehanna International Group LLP lowered its position in West Pharmaceutical Services, Inc. (NYSE:WST) by 62.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,127 shares of the medical instruments supplier’s stock after selling 8,488 shares during the period. Susquehanna International Group LLP’s holdings in West Pharmaceutical Services were worth $494,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in WST. Public Employees Retirement System of Ohio lifted its holdings in shares of West Pharmaceutical Services by 52.5% in the third quarter. Public Employees Retirement System of Ohio now owns 50,788 shares of the medical instruments supplier’s stock valued at $4,889,000 after purchasing an additional 17,487 shares in the last quarter. Sterling Capital Management LLC lifted its holdings in shares of West Pharmaceutical Services by 4.6% in the third quarter. Sterling Capital Management LLC now owns 342,460 shares of the medical instruments supplier’s stock valued at $32,965,000 after purchasing an additional 15,160 shares in the last quarter. Cubist Systematic Strategies LLC lifted its holdings in shares of West Pharmaceutical Services by 260.0% in the third quarter. Cubist Systematic Strategies LLC now owns 15,032 shares of the medical instruments supplier’s stock valued at $1,447,000 after purchasing an additional 10,857 shares in the last quarter. Zions Bancorporation lifted its holdings in shares of West Pharmaceutical Services by 25.5% in the third quarter. Zions Bancorporation now owns 14,622 shares of the medical instruments supplier’s stock valued at $1,408,000 after purchasing an additional 2,968 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in West Pharmaceutical Services by 162.3% during the third quarter. Janus Henderson Group PLC now owns 509,231 shares of the medical instruments supplier’s stock worth $49,019,000 after acquiring an additional 315,115 shares during the period. Institutional investors and hedge funds own 93.28% of the company’s stock.

WST has been the topic of a number of recent analyst reports. Jefferies Group upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating and lifted their price target for the stock from $96.00 to $115.00 in a report on Friday, September 15th. Bank of America lowered West Pharmaceutical Services from a “buy” rating to a “neutral” rating and set a $98.00 price target on the stock. in a report on Tuesday, October 17th. Wells Fargo & Company lifted their price target on West Pharmaceutical Services from $105.00 to $112.00 and gave the stock an “outperform” rating in a report on Friday, October 27th. Zacks Investment Research upgraded West Pharmaceutical Services from a “sell” rating to a “hold” rating in a report on Wednesday, September 27th. Finally, Stephens initiated coverage on West Pharmaceutical Services in a report on Tuesday, October 3rd. They set an “equal weight” rating and a $99.00 price target on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $106.00.

In other West Pharmaceutical Services news, CFO William J. Federici sold 21,000 shares of the firm’s stock in a transaction on Friday, December 8th. The stock was sold at an average price of $99.01, for a total value of $2,079,210.00. Following the completion of the sale, the chief financial officer now directly owns 190,493 shares of the company’s stock, valued at $18,860,711.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.90% of the company’s stock.

West Pharmaceutical Services, Inc. (WST) traded up $0.49 during trading hours on Monday, reaching $98.73. The company’s stock had a trading volume of 653,800 shares, compared to its average volume of 360,954. The company has a quick ratio of 1.87, a current ratio of 2.59 and a debt-to-equity ratio of 0.15. West Pharmaceutical Services, Inc. has a twelve month low of $77.97 and a twelve month high of $103.36. The stock has a market capitalization of $7,331.00, a P/E ratio of 42.56, a P/E/G ratio of 2.11 and a beta of 1.11.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, October 26th. The medical instruments supplier reported $0.67 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.14. West Pharmaceutical Services had a return on equity of 14.47% and a net margin of 12.12%. The business had revenue of $398.20 million during the quarter, compared to the consensus estimate of $386.02 million. During the same period last year, the business posted $0.53 earnings per share. The business’s revenue for the quarter was up 5.7% on a year-over-year basis. analysts forecast that West Pharmaceutical Services, Inc. will post 2.76 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This story was originally published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://www.watchlistnews.com/susquehanna-international-group-llp-sells-8488-shares-of-west-pharmaceutical-services-inc-wst/1771431.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with Analyst Ratings Network's FREE daily email newsletter.